Morgan Stanley’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Buy
219,862
+26,827
+14% +$39K ﹤0.01% 5654
2025
Q4
$222K Buy
193,035
+24,017
+14% +$33K ﹤0.01% 5890
2025
Q3
$228K Buy
169,018
+37,625
+29% +$42.7K ﹤0.01% 5846
2025
Q2
$124K Sell
131,393
-510,236
-80% -$331K ﹤0.01% 6051
2025
Q1
$296K Buy
641,629
+115,479
+22% +$72.9K ﹤0.01% 5568
2024
Q4
$389K Buy
526,150
+71,173
+16% +$85.8K ﹤0.01% 5527
2024
Q3
$714K Buy
454,977
+100,941
+29% +$180K ﹤0.01% 5232
2024
Q2
$595K Buy
354,036
+109,827
+45% +$197K ﹤0.01% 5210
2024
Q1
$586K Sell
244,209
-1,591,167
-87% -$3.42M ﹤0.01% 5237
2023
Q4
$2.81M Buy
1,835,376
+1,595,756
+666% +$1.9M ﹤0.01% 4746
2023
Q3
$261K Sell
239,620
-34,923
-13% -$61.3K ﹤0.01% 5461
2023
Q2
$629K Buy
274,543
+76,239
+38% +$202K ﹤0.01% 5103
2023
Q1
$482K Buy
198,304
+62,462
+46% +$143K ﹤0.01% 5279
2022
Q4
$259K Sell
135,842
-33,241
-20% -$70.7K ﹤0.01% 5560
2022
Q3
$405K Sell
169,083
-399,825
-70% -$1.11M ﹤0.01% 5371
2022
Q2
$1.06M Buy
568,908
+382,326
+205% +$729K ﹤0.01% 4984
2022
Q1
$390K Buy
186,582
+78,114
+72% +$217K ﹤0.01% 5554
2021
Q4
$427K Buy
108,468
+8,893
+9% +$43.2K ﹤0.01% 5639
2021
Q3
$479K Sell
99,575
-35,186
-26% -$144K ﹤0.01% 5523
2021
Q2
$619K Sell
134,761
-570,377
-81% -$2.75M ﹤0.01% 5387
2021
Q1
$4.14M Sell
705,138
-1,374,999
-66% -$9.52M ﹤0.01% 3604
2020
Q4
$7.11M Buy
2,080,137
+691,695
+50% +$1.32M ﹤0.01% 2874
2020
Q3
$2M Sell
1,388,442
-627,739
-31% -$1.12M ﹤0.01% 3659
2020
Q2
$4.02M Buy
2,016,181
+1,856,279
+1,161% +$3.64M ﹤0.01% 2897
2020
Q1
$312K Sell
159,902
-282,344
-64% -$840K ﹤0.01% 4642
2019
Q4
$1.83M Sell
442,246
-32,606
-7% -$126K ﹤0.01% 4112
2019
Q3
$1.43M Buy
474,852
+279,545
+143% +$865K ﹤0.01% 4065
2019
Q2
$1.23M Buy
195,307
+119,611
+158% +$716K ﹤0.01% 4112
2019
Q1
$421K Sell
75,696
-65,091
-46% -$395K ﹤0.01% 4653
2018
Q4
$935K Buy
140,787
+51,822
+58% +$420K ﹤0.01% 4323
2018
Q3
$950K Sell
88,965
-58,240
-40% -$667K ﹤0.01% 4576
2018
Q2
$1.77M Buy
147,205
+40,700
+38% +$416K ﹤0.01% 4194
2018
Q1
$912K Sell
106,505
-5,494
-5% -$50.8K ﹤0.01% 4606
2017
Q4
$1.11M Buy
111,999
+7,628
+7% +$79.3K ﹤0.01% 4468
2017
Q3
$1.28M Buy
104,371
+32,557
+45% +$481K ﹤0.01% 4259
2017
Q2
$1.18M Sell
71,814
-102,951
-59% -$1.59M ﹤0.01% 4250
2017
Q1
$2.5M Buy
174,765
+32,276
+23% +$479K ﹤0.01% 3612
2016
Q4
$1.97M Buy
142,489
+21,709
+18% +$348K ﹤0.01% 3943
2016
Q3
$2.18M Buy
120,780
+97,904
+428% +$1.58M ﹤0.01% 3436
2016
Q2
$328K Sell
22,876
-25,025
-52% -$339K ﹤0.01% 4671
2016
Q1
$573K Buy
47,901
+44,436
+1,282% +$466K ﹤0.01% 4344
2015
Q4
$47K Sell
3,465
-13,492
-80% -$166K ﹤0.01% 5739
2015
Q3
$182K Sell
16,957
-20,523
-55% -$224K ﹤0.01% 5127
2015
Q2
$302K Buy
37,480
+4,581
+14% +$33.6K ﹤0.01% 5024
2015
Q1
$218K Sell
32,899
-104,772
-76% -$715K ﹤0.01% 5162
2014
Q4
$876K Buy
137,671
+116,421
+548% +$938K ﹤0.01% 4252
2014
Q3
$210K Sell
21,250
-20,754
-49% -$222K ﹤0.01% 5119
2014
Q2
$473K Buy
42,004
+20,408
+94% +$219K ﹤0.01% 4614
2014
Q1
$262K Sell
21,596
-11,247
-34% -$144K ﹤0.01% 4963
2013
Q4
$414K Sell
32,843
-13,748
-30% -$219K ﹤0.01% 4585
2013
Q3
$776K Sell
46,591
-171,744
-79% -$2.88M ﹤0.01% 4008
2013
Q2
$3.32M Buy
+218,335
New +$3.32M ﹤0.01% 2714

Other funds holding LXRX